Results 211 to 220 of about 270,728 (301)

Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims We evaluated the impact of scenario‐based multifactorial control on the 3‐year incidence of fatal/non‐fatal cardiovascular disease (CVD) and associated healthcare costs in Asian patients with type 2 diabetes (T2D). Materials and Methods We applied the validated ‘ABC’ model to simulate the 3‐year impact of attaining multiple treatment ...
Lee‐Ling Lim   +9 more
wiley   +1 more source

Comparative Predictive Value of Three Visceral Adiposity Indices for Cardiovascular Disease: A 17.5‐Year Korean Cohort Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiovascular diseases (CVD) are the leading cause of death worldwide, with excess visceral adipose tissue (VAT) being identified as an independent indicator of poor cardiovascular outcomes. We examined the association between three indices of VAT, namely, metabolic score for visceral fat (METS‐VF), visceral adiposity index (VAI), and ...
A‐Ra Cho   +3 more
wiley   +1 more source

Sex Differences in Self-Rated Health and Cardiovascular Disease Events.

open access: yesJAMA Netw Open
Sud M   +13 more
europepmc   +1 more source

Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The global prevalence of obesity has more than doubled between 1990 and 2022, making it a significant public health concern. Obesity is associated with an increased risk of various complications, including cardiovascular diseases, type 2 diabetes, as well as increased risk for all‐cause mortality.
Cheli Melzer Cohen   +5 more
wiley   +1 more source

Serum IGF‐1 and the Risk of Cardio‐Kidney Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) increases cardiovascular and kidney disease risk. Insulin‐like growth factor 1 (IGF‐1) regulates metabolic and vascular function, but its role in long‐term cardio‐kidney outcomes (CKO) in MASLD remains unclear.
Yongin Cho   +4 more
wiley   +1 more source

Exercise blood pressure relative to fitness and cardiovascular outcomes: the EXERTION study. [PDF]

open access: yesEur Heart J
Schultz MG   +12 more
europepmc   +1 more source

Body Mass Index and All‐Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16–50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To examine the association between body mass index (BMI) and risk of all‐cause, cancer, and cardiovascular diseases (CVD) mortality among adults aged 16–50 years with and without type 2 diabetes (T2D). Materials and Methods We conducted a retrospective matched cohort study using primary care records from the Clinical Practice Research ...
Yijing Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy